BACKGROUND: Structural abnormalities of the anterior cingulate cortex (ACC) may interfere with the interaction of cortical and limbic networks involved in emotional regulation and contribute to chronic depressive syndromes in the elderly. This study examined the relationship of regional anterior cingulate cortical volumes with treatment remission of elderly depressed patients. We hypothesized that patients who failed to remit during a 12-week controlled treatment trial of escitalopram would exhibit smaller anterior cingulate gray matter volumes than patients who remitted. METHODS: The participants were 41 non-demented individuals with non-psychotic major depression. After a 2-week single-blind placebo period, subjects who still had a Hamilton Depression Rating Scale (HDRS) of 18 or greater received escitalopram 10 mg daily for 12 weeks. Remission was defined as a HDRS score of 7 or below for at least 2 consecutive weeks. The patient sample consisted of 22 depressed patients who achieved remission during the study and 19 depressed patients who remained symptomatic. High-resolution magnetization-prepared rapidly acquired gradient echo (MPRAGE) sequences were acquired on a 1.5 T scanner and regional ACC volumes were manually outlined (dorsal, rostral, anterior subgenual, and posterior subgenual). RESULTS: Repeated measure analyses revealed that patients who failed to remit following escitalopram treatment had smaller dorsal and rostral anterior cingulate gray matter volumes than patients who remitted, whereas subgenual cortical volumes did not differ between the groups. CONCLUSIONS: Structural abnormalities of the dorsal and rostral anterior cingulate may perpetuate late-life depression.
RCT Entities:
BACKGROUND:Structural abnormalities of the anterior cingulate cortex (ACC) may interfere with the interaction of cortical and limbic networks involved in emotional regulation and contribute to chronic depressive syndromes in the elderly. This study examined the relationship of regional anterior cingulate cortical volumes with treatment remission of elderly depressedpatients. We hypothesized that patients who failed to remit during a 12-week controlled treatment trial of escitalopram would exhibit smaller anterior cingulate gray matter volumes than patients who remitted. METHODS: The participants were 41 non-demented individuals with non-psychotic major depression. After a 2-week single-blind placebo period, subjects who still had a Hamilton Depression Rating Scale (HDRS) of 18 or greater received escitalopram 10 mg daily for 12 weeks. Remission was defined as a HDRS score of 7 or below for at least 2 consecutive weeks. The patient sample consisted of 22 depressedpatients who achieved remission during the study and 19 depressedpatients who remained symptomatic. High-resolution magnetization-prepared rapidly acquired gradient echo (MPRAGE) sequences were acquired on a 1.5 T scanner and regional ACC volumes were manually outlined (dorsal, rostral, anterior subgenual, and posterior subgenual). RESULTS: Repeated measure analyses revealed that patients who failed to remit following escitalopram treatment had smaller dorsal and rostral anterior cingulate gray matter volumes than patients who remitted, whereas subgenual cortical volumes did not differ between the groups. CONCLUSIONS:Structural abnormalities of the dorsal and rostral anterior cingulate may perpetuate late-life depression.
Authors: H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox Journal: Am J Psychiatry Date: 1999-05 Impact factor: 18.112
Authors: Christopher F Murphy; Faith M Gunning-Dixon; Matthew J Hoptman; Kelvin O Lim; Babak Ardekani; Jessica K Shields; Jan Hrabe; Dora Kanellopoulos; Bindu R Shanmugham; George S Alexopoulos Journal: Biol Psychiatry Date: 2006-11-21 Impact factor: 13.382
Authors: Ellen M Whyte; James Basinski; Panthea Farhi; Mary Amanda Dew; Amy Begley; Benoit H Mulsant; Charles F Reynolds Journal: J Clin Psychiatry Date: 2004-12 Impact factor: 4.384
Authors: D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Jason A Gandelman; Kimberly Albert; Brian D Boyd; Jung Woo Park; Meghan Riddle; Neil D Woodward; Hakmook Kang; Bennett A Landman; Warren D Taylor Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-09-21
Authors: Howard J Aizenstein; Alexander Khalaf; Sarah E Walker; Carmen Andreescu Journal: J Geriatr Psychiatry Neurol Date: 2013-12-30 Impact factor: 2.680
Authors: Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos Journal: Ann N Y Acad Sci Date: 2015-02-05 Impact factor: 5.691
Authors: Wenjun Li; Yang Wang; B Douglas Ward; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Psychiatr Res Date: 2016-12-12 Impact factor: 4.791
Authors: Yvette I Sheline; Brianne M Disabato; Jennifer Hranilovich; Carrie Morris; Gina D'Angelo; Carl Pieper; Tommaso Toffanin; Warren D Taylor; James R MacFall; Consuelo Wilkins; Deanna M Barch; Kathleen A Welsh-Bohmer; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy Journal: Am J Psychiatry Date: 2012-11 Impact factor: 18.112
Authors: Chunming Xie; Wenjun Li; Gang Chen; B Douglas Ward; Malgorzata B Franczak; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: Behav Brain Res Date: 2012-08-14 Impact factor: 3.332